Leukemia and Lymphoma
Country
United Kingdom
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Hematology
Q2
└
Oncology
Q2
└
Cancer Research
Q3
Publisher
SJR 2025
0.861
Q2
SJR Score
H-Index
109
Citations / Doc (2yr)
1.64
Total Docs. (latest)
369
Total Citations (3yr)
1,720
Publication type
Journals
ISSN
10292403, 10428194
Coverage
1989-2026
Journal Rank
#6,182
Subject Categories
Hematology
Q2
Oncology
Q2
Cancer Research
Q3
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 369 |
| Total Docs. (3 years) | 1,072 |
| Total Refs. | 12,899 |
| Total Citations (3 years) | 1,720 |
| Citable Docs. (3 years) | 679 |
| Citations / Doc. (2 years) | 1.64 |
| Ref. / Doc. | 34.96 |
| % Female | 44.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Leukemia and Lymphoma?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Leukemia and Lymphoma has an SJR of 0.861 and is ranked Q2.
What is the SJR and quartile of Leukemia and Lymphoma?
Leukemia and Lymphoma has an SJR (SCImago Journal Rank) of 0.861 and its best quartile is Q2.
What is the H-index of Leukemia and Lymphoma?
The H-index of Leukemia and Lymphoma is 109, meaning 109 of its articles have each been cited at least 109 times.
Is Leukemia and Lymphoma indexed in Scopus?
Yes. Leukemia and Lymphoma is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.